BioMimetic Therapeutics, Inc. Reports First Quarter 2011 Earnings Results

FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI), a biotechnology company specializing in the development and commercialization of innovative bioactive products to promote the healing of musculoskeletal injuries and diseases, today reported its financial results as of and for the three months ended March 31, 2011. For the three months ended March 31, 2011, the Company reported a net loss of $8.0 million, or $0.28 per diluted share, compared to a net loss of $8.5 million, or $0.39 per diluted share, for the same period in 2010. The Company ended the quarter with $83.7 million of cash and cash equivalents and investments.